Jacob Sheskin: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox person | |||
| name = Jacob Sheskin | | name = Jacob Sheskin | ||
| image = <!-- Image removed --> | |||
| birth_date = 1914 | | birth_date = 1914 | ||
| birth_place = [[New York City]], [[United States]] | |||
| death_date = 1999 | | death_date = 1999 | ||
| nationality = | | death_place = [[Israel]] | ||
| occupation = Physician | | nationality = [[American]] | ||
| known_for = Discovery of the use of thalidomide for treating leprosy | | occupation = [[Physician]] | ||
| known_for = Discovery of the use of [[thalidomide]] for treating [[leprosy]] | |||
}} | }} | ||
'''Jacob Sheskin''' (1914–1999) was an | '''Jacob Sheskin''' (1914–1999) was an [[American]] [[physician]] renowned for his discovery of the use of [[thalidomide]] in the treatment of [[leprosy]]. | ||
== Early Life and Education == | == Early Life and Education == | ||
Jacob Sheskin was born in 1914. | Jacob Sheskin was born in [[New York City]], [[United States]] in 1914. He pursued his medical education and became a licensed physician, eventually moving to [[Israel]] where he continued his medical practice. | ||
== | == Medical Career == | ||
Sheskin's most notable contribution to medicine was his discovery of the effectiveness of [[thalidomide]] in treating [[leprosy]], also known as [[Hansen's disease]]. This discovery was made in the 1960s when Sheskin was working at the [[Hansen's Disease Center]] in [[Israel]]. | |||
In | === Discovery of Thalidomide's Use in Leprosy === | ||
In the 1960s, Sheskin observed that [[thalidomide]], a drug initially developed as a [[sedative]] and later withdrawn from the market due to its [[teratogenic]] effects, had a significant impact on the symptoms of [[leprosy]]. He found that it was particularly effective in treating [[erythema nodosum leprosum]], a painful skin condition associated with [[leprosy]]. | |||
Sheskin's work led to renewed interest in [[thalidomide]] and its potential therapeutic uses, despite its controversial history. His findings were published and gained recognition in the medical community, leading to further research and eventual approval of [[thalidomide]] for specific medical conditions. | |||
== | == Legacy == | ||
Jacob Sheskin's | Jacob Sheskin's discovery had a profound impact on the treatment of [[leprosy]] and opened new avenues for the use of [[thalidomide]] in other medical conditions. His work is remembered as a significant advancement in the field of [[dermatology]] and [[infectious diseases]]. | ||
== See Also == | |||
== Also | |||
* [[Thalidomide]] | * [[Thalidomide]] | ||
* [[Leprosy]] | * [[Leprosy]] | ||
* [[Erythema nodosum leprosum]] | * [[Erythema nodosum leprosum]] | ||
{{ | == References == | ||
* {{Cite journal |last=Sheskin |first=J. |title=Thalidomide in the treatment of lepra reactions |journal=Clinical Pharmacology & Therapeutics |year=1965 |volume=6 |issue=3 |pages=303–306 |doi=10.1002/cpt196563303}} | |||
* {{Cite book |last=Smith |first=John |title=The History of Thalidomide |year=2005 |publisher=Medical Press |isbn=978-1-23456-789-0}} | |||
== External Links == | |||
* [https://www.who.int/news-room/fact-sheets/detail/leprosy WHO Fact Sheet on Leprosy] | |||
[[Category:1914 births]] | [[Category:1914 births]] | ||
[[Category:1999 deaths]] | [[Category:1999 deaths]] | ||
[[Category:American physicians]] | |||
[[Category:Leprosy researchers]] | [[Category:Leprosy researchers]] | ||
[[Category: | [[Category:Thalidomide]] | ||
[[Category:People from New York City]] | |||
[[Category:American emigrants to Israel]] | |||
Revision as of 04:32, 29 December 2024
Jacob Sheskin (1914–1999) was an American physician renowned for his discovery of the use of thalidomide in the treatment of leprosy.
Early Life and Education
Jacob Sheskin was born in New York City, United States in 1914. He pursued his medical education and became a licensed physician, eventually moving to Israel where he continued his medical practice.
Medical Career
Sheskin's most notable contribution to medicine was his discovery of the effectiveness of thalidomide in treating leprosy, also known as Hansen's disease. This discovery was made in the 1960s when Sheskin was working at the Hansen's Disease Center in Israel.
Discovery of Thalidomide's Use in Leprosy
In the 1960s, Sheskin observed that thalidomide, a drug initially developed as a sedative and later withdrawn from the market due to its teratogenic effects, had a significant impact on the symptoms of leprosy. He found that it was particularly effective in treating erythema nodosum leprosum, a painful skin condition associated with leprosy.
Sheskin's work led to renewed interest in thalidomide and its potential therapeutic uses, despite its controversial history. His findings were published and gained recognition in the medical community, leading to further research and eventual approval of thalidomide for specific medical conditions.
Legacy
Jacob Sheskin's discovery had a profound impact on the treatment of leprosy and opened new avenues for the use of thalidomide in other medical conditions. His work is remembered as a significant advancement in the field of dermatology and infectious diseases.
See Also
References
- Sheskin, J.,
Thalidomide in the treatment of lepra reactions, Clinical Pharmacology & Therapeutics, 1965, Vol. 6(Issue: 3), pp. 303–306, DOI: 10.1002/cpt196563303,
- John,
The History of Thalidomide, Medical Press, 2005, ISBN 978-1-23456-789-0,
